ArticleFrontiers in human neuroscience2026
From metric to model: a five-stage pipeline for building and sustaining valid AI predictive systems in consumer neuroscience.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The application of machine learning to consumer neuroscience has made it possible, in principle, to predict consumer responses from media assets alone. However, the pursuit of model sophistication has outpaced attention to a foundational constraint: the quality of any predictive artificial intelligence (AI) system is bounded by the quality of the neurophysiological and biometric data used to train it, and by the rigor of the modeling procedures applied to those data. This article argues that persistent problems of low metric reliability, poor cross-metric consistency, and the broader replication crisis have left the field building predictive systems on an insecure measurement foundation. Anchored in the framework for neurometric validation established by Ramsøy (2019), the paper offers a conceptual synthesis and agenda-setting framework for the AI era: a five-stage pipeline comprising (1) Metric Mapping, the theory-driven identification and pre-screening of candidate neurophysiological and biometric measures; (2) Psychometric Validation, the formal assessment of each metric's sensitivity, specificity, validity, and reliability; (3) Discriminatory Ability, an assessment of whether a metric produces meaningful score distributions across real-world commercial stimuli; (4) Principled Data Scaling and Model Development, covering both the large-scale data collection and the modeling and validation procedures required for robust prediction; and (5) Model Governance and Drift Prevention, the ongoing monitoring, retraining, and calibration required to maintain predictive validity over time. The individual components draw on established practice in psychometrics, measurement science, and applied machine learning; the contribution lies in integrating them into a coherent, domain-specific architecture for consumer neuroscience, and in making explicit a criterion-Discriminatory Ability-that is widely assumed but rarely tested in applied advertising research. The pipeline is offered not as a validated standard but as a structured research agenda and a basis for future work on standardization, certification, and governance, with the aim of shifting the field from a model-centric toward a validation-centric culture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.